Suppr超能文献

腹膜透析相关性腹膜炎反复发作:181 例连续病例的回顾性分析。

Repeat peritonitis in peritoneal dialysis: retrospective review of 181 consecutive cases.

机构信息

Department of Medicine & Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China.

出版信息

Clin J Am Soc Nephrol. 2011 Apr;6(4):827-33. doi: 10.2215/CJN.05370610. Epub 2010 Dec 23.

Abstract

BACKGROUND AND OBJECTIVES

The clinical behavior of repeat-peritonitis episodes, defined as peritonitis with the same organism occurring more than 4 weeks after completion of therapy for a prior episode, is poorly understood.

DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We compared outcomes of 181 episodes of repeat peritonitis from 1995 to 2009 (Repeat Group) with 91 episodes of relapsing peritonitis (Relapsing Group) and 125 episodes of peritonitis preceded 4 weeks or longer by another episode with a different organism (Control Group).

RESULTS

In Repeat Group, 24% were due to Staphylococcus aureus, as compared with 5.5% in Relapsing Group and 15% in Control Group. The majority of the organisms causing relapsing peritonitis were Gram negative (62%), whereas the majority of that in Repeat Group were Gram positive (56%). Repeat Group had a lower complete-cure rate (70.7% versus 54.9%) than Relapsing Group, but rates of primary response, catheter removal, and mortality were similar. Repeat Group had a higher primary response rate (89.0% versus 73.6%) and a lower rate of catheter removal (6.1% versus 15.2%) than Control Group, whereas the complete-cure rate and mortality were similar. Repeat Group had a higher risk of developing relapsing (14.3% versus 2.2%) and repeat peritonitis (26.1% versus 5.4%) than Control Group, whereas the risk of recurrent peritonitis was similar.

CONCLUSIONS

Repeat peritonitis is a distinct clinical entity. Although repeat-peritonitis episodes generally have a satisfactory response to antibiotic, they have a substantial risk of developing further relapsing or repeat peritonitis.

摘要

背景与目的

反复发作性腹膜炎是指在完成前一次腹膜炎的治疗后 4 周以上,同一病原体再次引起腹膜炎。目前对其临床特征尚缺乏了解。

设计、地点、参与者和测量方法:我们比较了 1995 年至 2009 年 181 例反复发作性腹膜炎(重复组)与 91 例复发性腹膜炎(复发组)和 125 例间隔 4 周或更长时间、由不同病原体引起的腹膜炎(对照组)的结局。

结果

重复组中 24%由金黄色葡萄球菌引起,而复发组中为 5.5%,对照组中为 15%。引起复发性腹膜炎的大多数病原体为革兰阴性菌(62%),而重复组中的大多数病原体为革兰阳性菌(56%)。与复发组(70.7%)相比,重复组的完全治愈率较低(54.9%),但初次反应率、导管去除率和死亡率相似。与对照组相比,重复组初次反应率较高(89.0% vs. 73.6%),导管去除率较低(6.1% vs. 15.2%),而完全治愈率和死亡率相似。与对照组相比,重复组发生复发(14.3% vs. 2.2%)和再次发生腹膜炎(26.1% vs. 5.4%)的风险更高,而复发腹膜炎的风险相似。

结论

反复发作性腹膜炎是一种独特的临床实体。尽管反复发作性腹膜炎通常对抗生素有满意的反应,但它们有发生进一步复发或再次发生腹膜炎的很大风险。

相似文献

引用本文的文献

8
Renal Replacement Therapy in the Pediatric Critical Care Unit.儿科重症监护病房中的肾脏替代治疗
J Pediatr Intensive Care. 2016 Jun;5(2):59-63. doi: 10.1055/s-0035-1564736. Epub 2015 Sep 30.

本文引用的文献

8
Microbiology and outcomes of peritonitis in North America.北美腹膜炎的微生物学及预后
Kidney Int Suppl. 2006 Nov(103):S55-62. doi: 10.1038/sj.ki.5001916.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验